Pharma Journalist -

Incyte and Cellenkos, Inc., a privately held, clinical stage biotech company,  announced a development collaboration to investigate the combination of ruxolitinib (Jakafi) and CK0804,…
Read More...

Biogen Inc. and Sage Therapeutics, Inc. announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for…
Read More...

SMi Reports: Speaker interview released for SMi’s 2nd Annual AI in Drug Discovery Conference taking place on 15 – 16 March 2021 as a virtual conference with online access only.…
Read More...

BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced an agreement to supply Mainland China with an initial 100 million doses of their BNT162 mRNA-based vaccine…
Read More...

Novartis has entered an agreement to acquire Cadent Therapeutics, a Cambridge, Massachusetts based neuroscience company. The acquisition adds two new clinical stage programs to the…
Read More...

Two randomized, controlled Phase 3 clinical trials have begun evaluating investigational monoclonal antibodies for their safety and efficacy in treating people hospitalized with…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, confirmed that the…
Read More...

GlaxoSmithKline plc announced the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for the treatment of adult patients with active lupus nephritis (LN) who are…
Read More...

Ultragenyx Pharmaceutical Inc. a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare diseases, and Mereo…
Read More...

SMi Reports: The 8th annual Pre-filled Syringes East Coast conference is returning as a virtually conference on April 26th – 27th 2021. SMi Group are delighted to have Susan Neadle,…
Read More...